Oncology Institute (TOIIW) Shares Outstanding (Weighted Average) (2019 - 2026)

Oncology Institute (TOIIW) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $101.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 32.04% year-over-year to $101.8 million; the trailing twelve-month figure through Mar 2026 stood at $101.8 million (up 32.04% YoY), and the FY2025 full-year result was $92.4 million, up 23.11% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $101.8 million, up from $89.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $101.8 million in Q1 2026 and bottomed at $72.2 million in Q3 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $74.2 million (2023), against an average of $77.4 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) gained 0.27%; it then soared 32.04% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $72.8 million in 2022, then climbed by 1.31% to $73.7 million in 2023, then climbed by 1.76% to $75.0 million in 2024, then gained by 19.04% to $89.3 million in 2025, then rose by 13.96% to $101.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $101.8 million (Q1 2026), $89.3 million (Q3 2025), and $85.2 million (Q2 2025), per Business Quant data.

Peer Comparison